UroGen Expands Oncology Pipeline Through IntraGel Deal
PRINCETON, New Jersey, August 20, 2026 UroGen Pharma Ltd. announced a strategic collaboration and investment agreement with IntraGel Therapeutics,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
PRINCETON, New Jersey, August 20, 2026 UroGen Pharma Ltd. announced a strategic collaboration and investment agreement with IntraGel Therapeutics,...
PROVIDENCE, R.I., August 18, 2026 GT Medical Technologies, Inc. announced new clinical findings suggesting that its GammaTile® targeted radiation...
SAN CARLOS, Calif. & SEATTLE, Aug. 18, 2026 BeOne Medicines Ltd., together with the BeOne Care Foundation and The...
Milwaukee, Wisconsin, August 17, 2026 The Society for Immunotherapy of Cancer (SITC) has announced the 2026 Class of Fellows...
Austin, Texas — August 17, 2026 Faeth Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted...
New York, United States, August 14, 2026 BrainStorm Cell Therapeutics Inc. announced its financial results for the second quarter...
Tokyo, Japan, August 16, 2026 Kyowa Kirin Co., Ltd. has selected Cognizant and Benchling as partners to implement an...
New York, United States, August 14, 2026 Actinium Pharmaceuticals, Inc. announced new intellectual property and manufacturing developments supporting its...
Toronto, Canada and Dallas, Texas, August 13, 2026 Perimeter Medical Imaging AI Inc. has announced that Intermountain Health has...
Caesarea, Israel, August 13, 2026 IceCure Medical Ltd., a developer of minimally invasive cryoablation technology for tumor treatment, has...
